FDA Approves Moxeza
FDA Approves Moxeza for Bacterial Conjunctivitis
November 19, 2010 - The United States Food and Drug Administration (FDA) has approved Moxeza (moxifloxacin hydrochloride ophthalmic solution), a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.Posted: November 2010
Moxeza (moxifloxacin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
